PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,613,000 | +106.3% | 1,269,799 | +135.4% | 1.36% | +220.6% |
| Q2 2020 | $1,751,000 | -0.6% | 539,450 | -13.7% | 0.42% | -39.7% |
| Q1 2020 | $1,762,000 | +0.6% | 624,783 | +15.8% | 0.70% | +65.7% |
| Q4 2019 | $1,751,000 | +50.3% | 539,450 | 0.0% | 0.42% | +46.4% |
| Q3 2019 | $1,165,000 | -31.2% | 539,450 | 0.0% | 0.29% | -32.2% |
| Q2 2019 | $1,694,000 | -24.2% | 539,450 | -10.2% | 0.43% | -23.8% |
| Q1 2019 | $2,235,000 | +13.2% | 600,750 | -11.8% | 0.56% | +9.4% |
| Q4 2018 | $1,975,000 | +19.6% | 680,950 | +8.5% | 0.51% | +30.7% |
| Q3 2018 | $1,651,000 | +108.7% | 627,800 | +85.7% | 0.39% | +100.5% |
| Q2 2018 | $791,000 | – | 338,141 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |